(MedPage Today) — Most patients with early, active axial spondyloarthritis (axSpA) who quickly received a tumor necrosis factor (TNF) inhibitor experienced remission, and it didn’t matter whether or not they had intestinal inflammation at baseline…
Source link : https://www.medpagetoday.com/rheumatology/arthritis/116143
Author :
Publish date : 2025-06-19 15:00:00
Copyright for syndicated content belongs to the linked Source.
